<--- Back to Details
First PageDocument Content
Antiprotozoal agents / Neglected diseases / Tropical diseases / Infectious diseases / African trypanosomiasis / Nifurtimox / Drugs for Neglected Diseases Initiative / Eflornithine / Melarsoprol / Chemistry / Medicine / Organic chemistry
Date: 2011-11-28 19:21:12
Antiprotozoal agents
Neglected diseases
Tropical diseases
Infectious diseases
African trypanosomiasis
Nifurtimox
Drugs for Neglected Diseases Initiative
Eflornithine
Melarsoprol
Chemistry
Medicine
Organic chemistry

Add to Reading List

Source URL: dndi.org

Download Document from Source Website

File Size: 42,63 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 16wfh - View Document

Biomarkcrs in Cancer ChemepreveritFon Miller A.B., Bar1ncl H., Baffefla, P., Dragated, L. and Vo nia, H. edc ARC Scientific Publications No. 154 International Agency for Research on Cancer, Lyon, 2001  ornithine and Bowm

Biomarkcrs in Cancer ChemepreveritFon Miller A.B., Bar1ncl H., Baffefla, P., Dragated, L. and Vo nia, H. edc ARC Scientific Publications No. 154 International Agency for Research on Cancer, Lyon, 2001 ornithine and Bowm

DocID: VR7I - View Document

Access to Drugs for African Trypanosomiasis (sleeping sickness) Due to difficulties by some GeoSentinel sites in obtaining drugs for patients acutely ill with sleeping sickness, GeoSentinel has worked with ISTM WHO Liais

Access to Drugs for African Trypanosomiasis (sleeping sickness) Due to difficulties by some GeoSentinel sites in obtaining drugs for patients acutely ill with sleeping sickness, GeoSentinel has worked with ISTM WHO Liais

DocID: VIIR - View Document

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness Caecilia Schmid1,2, Andrea Kuemmerle1,2¤, Johannes Blum1,2, Salah Ghabri3, Victor Kande4

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness Caecilia Schmid1,2, Andrea Kuemmerle1,2¤, Johannes Blum1,2, Salah Ghabri3, Victor Kande4

DocID: Sz7S - View Document

NECT IN BRIEF • AN IMPROVED TREATMENT OPTION The Nifurtimox-Eflornithine Combination Therapy (NECT) is a new, improved treatment option for stage 2 (advanced stage) Human African trypanosomiasis (HAT) also known as sl

NECT IN BRIEF • AN IMPROVED TREATMENT OPTION The Nifurtimox-Eflornithine Combination Therapy (NECT) is a new, improved treatment option for stage 2 (advanced stage) Human African trypanosomiasis (HAT) also known as sl

DocID: SpRW - View Document